» Articles » PMID: 33008889

PH-dependent Pyridoxine Transport by SLC19A2 and SLC19A3: Implications for Absorption in Acidic Microclimates

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2020 Oct 3
PMID 33008889
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

SLC19A2 and SLC19A3, also known as thiamine transporters (THTR) 1 and 2, respectively, transport the positively charged thiamine (vitamin B1) into cells to enable its efficient utilization. SLC19A2 and SLC19A3 are also known to transport structurally unrelated cationic drugs, such as metformin, but whether this charge selectivity extends to other molecules, such as pyridoxine (vitamin B6), is unknown. We tested this possibility using Madin-Darby canine kidney II (MDCKII) cells and human embryonic kidney 293 (HEK293) cells for transfection experiments, and also using Caco-2 cells as human intestinal epithelial model cells. The stable expression of SLC19A2 and SLC19A3 in MDCKII cells (as well as their transient expression in HEK293 cells) led to a significant induction in pyridoxine uptake at pH 5.5 compared with control cells. The induced uptake was pH-dependent, favoring acidic conditions over neutral to basic conditions, and protonophore-sensitive. It was saturable as a function of pyridoxine concentration, with an apparent of 37.8 and 18.5 μm, for SLC19A2 and SLC19A3, respectively, and inhibited by the pyridoxine analogs pyridoxal and pyridoxamine as well as thiamine. We also found that silencing the endogenous SLC19A3, but not SLC19A2, of Caco-2 cells with gene-specific siRNAs lead to a significant reduction in carrier-mediated pyridoxine uptake. These results show that SLC19A2 and SLC19A3 are capable of recognizing/transporting pyridoxine, favoring acidic conditions for operation, and suggest a possible role for these transporters in pyridoxine transport mainly in tissues with an acidic environment like the small intestine, which has an acidic surface microclimate.

Citing Articles

Substrate transport and drug interaction of human thiamine transporters SLC19A2/A3.

Li P, Zhu Z, Wang Y, Zhang X, Yang C, Zhu Y Nat Commun. 2024; 15(1):10924.

PMID: 39738067 PMC: 11686366. DOI: 10.1038/s41467-024-55359-8.


Causal effects of gut microbiota on gout and hyperuricemia: insights from genome-wide Mendelian randomization, RNA-sequencing, 16S rRNA sequencing, and metabolomes.

Liu X, Feng Z, Zhang F, Wang B, Wei Z, Liao N Biosci Rep. 2024; 44(11).

PMID: 39492788 PMC: 11598824. DOI: 10.1042/BSR20240595.


Structural basis of thiamine transport and drug recognition by SLC19A3.

Gabriel F, Spriestersbach L, Fuhrmann A, Jungnickel K, Mostafavi S, Pardon E Nat Commun. 2024; 15(1):8542.

PMID: 39358356 PMC: 11447181. DOI: 10.1038/s41467-024-52872-8.


Rare Diseases Linked to Mutations in Vitamin Transporters Expressed in the Human Blood-Brain Barrier.

Yee S, Wang J, Giacomini K Clin Pharmacol Ther. 2024; 116(6):1513-1520.

PMID: 39234898 PMC: 11567784. DOI: 10.1002/cpt.3433.


The riboflavin (vitamin B2) transporter protein (SmaRT) of the human intravascular parasitic trematode Schistosoma mansoni.

Dadara A, Gondane R, Skelly P Heliyon. 2024; 10(7):e28271.

PMID: 38601580 PMC: 11004526. DOI: 10.1016/j.heliyon.2024.e28271.


References
1.
Liang X, Chien H, Yee S, Giacomini M, Chen E, Piao M . Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3). Mol Pharm. 2015; 12(12):4301-10. PMC: 4800991. DOI: 10.1021/acs.molpharmaceut.5b00501. View

2.
Yamashiro T, Yasujima T, Ohta K, Inoue K, Yuasa H . Identification of the amino acid residue responsible for the myricetin sensitivity of human proton-coupled folate transporter. Sci Rep. 2019; 9(1):18105. PMC: 6889420. DOI: 10.1038/s41598-019-54367-9. View

3.
Said Z, Subramanian V, Vaziri N, Said H . Pyridoxine uptake by colonocytes: a specific and regulated carrier-mediated process. Am J Physiol Cell Physiol. 2008; 294(5):C1192-7. DOI: 10.1152/ajpcell.00015.2008. View

4.
Said H . Recent advances in transport of water-soluble vitamins in organs of the digestive system: a focus on the colon and the pancreas. Am J Physiol Gastrointest Liver Physiol. 2013; 305(9):G601-10. PMC: 3840235. DOI: 10.1152/ajpgi.00231.2013. View

5.
Ohashi R, Tamai I, Nezu Ji J, Nikaido H, Hashimoto N, Oku A . Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol. 2001; 59(2):358-66. DOI: 10.1124/mol.59.2.358. View